Health Canada drug identification number

DIN 02556618 — AURO-ATOVAQUONE 750 MG

AURO-ATOVAQUONE is a suspension of Atovaquone marketed by AURO PHARMA INC. The full Atovaquone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02556618
Brand name
AURO-ATOVAQUONE
Active ingredient
Atovaquone
Strength
750 MG
Dosage form
SUSPENSION
Route
ORAL
Manufacturer
AURO PHARMA INC
Health Canada status
MARKETED
Drug class
Antiprotozoal agent (hydroxynaphthoquinone)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Atovaquone products

DINBrandStrengthFormManufacturerStatus
02528495 GLN-ATOVAQUONE 750 MG SUSPENSION GLENMARK PHARMACEUTICALS CANADA INC. MARKETED
02217422 MEPRON 750 MG SUSPENSION GLAXOSMITHKLINE INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.